317 related articles for article (PubMed ID: 12092782)
21. Effect of Rift Valley fever virus on pregnant and non-pregnant local Barki ewes after artificial infection.
Wasel M; Atia MM; Mohsen A; el-Sayed M; Zaki K
Arch Exp Veterinarmed; 1990; 44(5):645-8. PubMed ID: 2096784
[TBL] [Abstract][Full Text] [Related]
22. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of lamb and calf responses to Rift Valley fever MP-12 vaccination.
Wilson WC; Bawa B; Drolet BS; Lehiy C; Faburay B; Jasperson DC; Reister L; Gaudreault NN; Carlson J; Ma W; Morozov I; McVey DS; Richt JA
Vet Microbiol; 2014 Aug; 172(1-2):44-50. PubMed ID: 24856133
[TBL] [Abstract][Full Text] [Related]
25. Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep.
Morrill JC; Laughlin RC; Lokugamage N; Pugh R; Sbrana E; Weise WJ; Adams LG; Makino S; Peters CJ
Vaccine; 2013 Jan; 31(3):559-65. PubMed ID: 23153443
[TBL] [Abstract][Full Text] [Related]
26. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
[TBL] [Abstract][Full Text] [Related]
27. Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
Wichgers Schreur PJ; Kant J; van Keulen L; Moormann RJ; Kortekaas J
Vaccine; 2015 Mar; 33(12):1459-64. PubMed ID: 25665959
[TBL] [Abstract][Full Text] [Related]
28. Rift Valley fever vaccine--antibody and immune response in cattle to a live and an inactivated vaccine.
Barnard BJ
J S Afr Vet Assoc; 1979 Sep; 50(3):155-7. PubMed ID: 551199
[TBL] [Abstract][Full Text] [Related]
29. Comparative efficacy of two next-generation Rift Valley fever vaccines.
Kortekaas J; Oreshkova N; van Keulen L; Kant J; Bosch BJ; Bouloy M; Moulin V; Goovaerts D; Moormann RJ
Vaccine; 2014 Sep; 32(39):4901-8. PubMed ID: 25050973
[TBL] [Abstract][Full Text] [Related]
30. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Ikegami T
Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
[TBL] [Abstract][Full Text] [Related]
31. Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep.
Matsiela MS; Naicker L; Khoza T; Mokoena N
Virol J; 2023 Oct; 20(1):221. PubMed ID: 37789354
[TBL] [Abstract][Full Text] [Related]
32. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
Wallace DB; Ellis CE; Espach A; Smith SJ; Greyling RR; Viljoen GJ
Vaccine; 2006 Nov; 24(49-50):7181-9. PubMed ID: 16870311
[TBL] [Abstract][Full Text] [Related]
33. Abortion in vaccinated sheep and cattle after challenge with Rift Valley fever virus.
Yedloutschnig RJ; Dardiri AH; Mebus CA; Walker JS
Vet Rec; 1981 Oct; 109(17):383-4. PubMed ID: 7340068
[No Abstract] [Full Text] [Related]
34. Safety and immunogenicity of Onderstepoort Biological Products' Rift Valley fever Clone 13 vaccine in sheep and goats under field conditions in Senegal.
Lo MM; Mbao V; Sierra P; Thiongane Y; Diop M; Donadeu M; Dungu B
Onderstepoort J Vet Res; 2015 May; 82(1):857. PubMed ID: 26244679
[TBL] [Abstract][Full Text] [Related]
35. Vertical transmission of Rift Valley fever virus without detectable maternal viremia.
Antonis AF; Kortekaas J; Kant J; Vloet RP; Vogel-Brink A; Stockhofe N; Moormann RJ
Vector Borne Zoonotic Dis; 2013 Aug; 13(8):601-6. PubMed ID: 23682700
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of Rift Valley fever in west Africa. 1. Serological investigation of small ruminants in Niger].
Akakpo AJ; Saluzzo JF; Bada R; Bornarel P; Sarradin P
Bull Soc Pathol Exot; 1991; 84(3):217-24. PubMed ID: 1764749
[TBL] [Abstract][Full Text] [Related]
37. The spread of Rift Valley fever and approaches to its control.
Shope RE; Peters CJ; Davies FG
Bull World Health Organ; 1982; 60(3):299-304. PubMed ID: 6982772
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.
Miller MM; Bennett KE; Drolet BS; Lindsay R; Mecham JO; Reeves WK; Weingartl HM; Wilson WC
Clin Vaccine Immunol; 2015 Aug; 22(8):930-7. PubMed ID: 26041042
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
[TBL] [Abstract][Full Text] [Related]
40. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
